Revolutionary alternative for antibiotic susceptibility test
Resistell AG
Incorporated
05.04.2018Headquarters
MuttenzSupport
Resistell is revolutionizing Antibiotic Susceptibility Testing (AST) with the world’s fastest platform. Our CE IVD-certified AST for bloodstream infections has been validated in two clinical studies with over 500 patient samples, achieving more than 95% accuracy. The current version of our Phenotech device delivers ultra-rapid phenotypic AST results in just 2 hours—a speed unmatched by any other technology. To date, we have secured CHF 17 million in equity and CHF 4 million in grants. We are now raising funds for high-throughput device, leveraging our cutting-edge, highly de-risked nanomotion technology. The prototype of a high-throughput device, developed with an industrial partner, is ready for further advancement.
News
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
TechTour Growth: A showcase for Switzerland’s Deeptech prowess (startupticker.ch)
New additions to startups’ board of directors (startupticker.ch)
Resistell’s convincing study results published in Nature Communications (startupticker.ch)
Twenty-eight startups selected for the Innosuisse Scale up Coaching (startupticker.ch)
TechTour Growth Health showcases Swiss health solutions (startupticker.ch)
Innovative Medicines for Tuberculosis relies on Resistell’s technology (startupticker.ch)
First patients recruited for Resistell’s international clinical study (startupticker.ch)
Resistell raises CHF8.5 million to bring its first product to the market (startupticker.ch)
Resistell raises CHF 8.5 million to complete clinical trials for antibiotic susceptibility testing: interview with CEO Danuta Cichocka (venturelab.swiss)
Pfizer backs medtech startup Resistell (startupticker.ch)
Sino-Swiss Pitchinar: Selected Swiss biotech startups pitch to Chinese investors and enterprises (venturelab.swiss)
Resistell enters clinical studies (startupticker.ch)
Resistell CEO Danuta Cichocka: ‘You must strongly believe in your idea and convince the world that it cannot live without your solution’ (venturelab.swiss)
A new prize for AgroSustain (startupticker.ch)
Switzerland's TOP biotech startups 2020 (venturelab.swiss)
EIC grants to drive Swiss innovation projects forward (startupticker.ch)
Resistell receives €2.5M EIC Accelerator grant and equity financing offer from EIC (venturelab.swiss)
10 Swiss Biotech Startups to Watch in 2020 (venturelab.swiss)
TOP 100 - Meet the 5 Best Newcomers Startups of 2019 Ranking (venturelab.swiss)
Milestones news
Cellectric, Resistell and Lausanne University Hospital will collaborate on a joint Eurostars project
Resistell joins SPEARHEAD to address the silent pandemic of antimicrobial resistance (AMR)
Resistell presented the science behind the rapid AST method during the AMR Berlin 2019 conference
